1. Practice parameter;Doody;Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology,2001
2. http://www.fda.gov/cder/drug/advisory/antipsychotics.htm
3. Food and Drug Administration. http://www.fda.gov/medwatch/SAFETY/2004/risperdal.htm
4. Dear Healthcare Professional. http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-Department/risperdal1_e.html